Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
REGN5837
i
Other names:
REGN5837
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Regeneron
Drug class:
CD28 agonist, CD22 inhibitor
Related drugs:
‹
SAR442257 (4)
SAR443216 (1)
ICOSL vIgD (0)
NILK-3801 (0)
REGN5668 (0)
RG6333 (0)
REGN5678 (0)
BL-22 (0)
Imtox19/Imtox22 (0)
epratuzumab (0)
IgG-RFB4-SMPT-dgA (0)
epratuzumab Y-90 (0)
YT-19/22 (0)
anti CD19/CD22 CAR NK cells (0)
TAC-001 (0)
JNJ-8780 (0)
SAR442257 (4)
SAR443216 (1)
ICOSL vIgD (0)
NILK-3801 (0)
REGN5668 (0)
RG6333 (0)
REGN5678 (0)
BL-22 (0)
Imtox19/Imtox22 (0)
epratuzumab (0)
IgG-RFB4-SMPT-dgA (0)
epratuzumab Y-90 (0)
YT-19/22 (0)
anti CD19/CD22 CAR NK cells (0)
TAC-001 (0)
JNJ-8780 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login